South Wales, Nov. 18 -- UK Intellectual Property Office has received a patent application (GB2610321.8) with the title ‘Loratadine Nanoformulation for Use in Treating Osteosarcoma.’

Here are the other details related to the patent application:

Status: Filed

Filing Date: 2026-05-01

Owner(s): Marwa M. Ellithy, Abdulrahman M. Saleh, Mohamed Nabil Ibrahim, Eman Fawzy El Azab, Wael Alzahrani, Fawaz O. Alenazy, Khaled Alzhrani, Awadh Alanazi, Tamer Mahmoud Nafee, and Jouf University

Disclaimer: Curated by HT Syndication.